Today: 20 March 2026
Subscribe
Browse Category

TSX:CSU 10 November 2025 - 4 February 2026

Constellation Software hits a 1-year low — why analysts still see upside in CSU

Constellation Software hits a 1-year low — why analysts still see upside in CSU

Constellation Software shares hovered near a 52-week low Wednesday on the Toronto Stock Exchange, trading around C$2,342 after a steep two-day drop. Several banks cut price targets, but analysts tracked by MarketBeat kept a “moderate buy” consensus. The Sequoia Fund called the valuation “compelling” in a shareholder letter. Leadership changes continue after founder Mark Leonard stepped down last September.
4 February 2026
·
Constellation Software’s 48% slide has investors split as AI fears rattle software stocks

Constellation Software’s 48% slide has investors split as AI fears rattle software stocks

Constellation Software shares have fallen about 48% in the past year amid investor concerns over AI’s impact on software pricing and a CEO transition. Founder Mark Leonard stepped down for health reasons, with Mark Miller now president. Ruane Cunniff says the stock trades at a high-teens forward P/E and sees the valuation as compelling despite ongoing uncertainty.
3 February 2026
··
Fresh CSU.DB buy-and-short levels land as Constellation’s March coupon reset nears

Fresh CSU.DB buy-and-short levels land as Constellation’s March coupon reset nears

A technical report set new buy and short targets for Constellation Software’s Series 1 debentures (CSU.DB), recommending buys near 116.78 and shorts near 119.15. The CPI-linked coupon resets March 31 at 8.6%. CSU.DB last traded near 117.78% of face value, after peaking at 120.15%. The bond was rated “Neutral” with a warning that key triggers may have already passed.
3 February 2026
Constellation Software stock tumbles to new 52-week low as investors question acquisition-led growth

Constellation Software stock tumbles to new 52-week low as investors question acquisition-led growth

Constellation Software shares fell 6.3% to C$3,008.19 in Toronto Wednesday, touching a new 52-week low and leaving the stock down 43% from last year’s peak. The drop follows concerns over slowing organic growth despite a recent RBC price target hike to C$5,600. Constellation’s market cap stood near C$68 billion. The stock trades at 72.7 times earnings, well above the Canadian software industry average.
14 January 2026
·
Constellation Software (CSU.TO) Stock Plunges on Founder’s Exit – Analysts See 58% Upside

CSU Stock Today (Nov 10, 2025): Constellation Software Hits New 52‑Week Low as BMO Trims Target; Q3 Revenue +16% and $1 Dividend Reaffirmed

Constellation Software shares hit a new 52-week low Monday, trading near C$3,262 on the TSX after BMO Capital cut its price target to C$4,600 and Q3 revenue missed consensus. Q3 revenue rose 16% to US$2.948 billion, with net income at US$210 million. The S&P/TSX Composite gained 1.1% intraday, highlighting CSU’s stock-specific decline. The board reaffirmed a US$1.00 quarterly dividend.
10 November 2025
···

Stock Market Today

  • Regeneus Ltd (RGS.AX) Jumps 33% on Heavy Volume, Signals Short-Term Upside
    March 19, 2026, 10:42 PM EDT. Regeneus Ltd (RGS.AX) surged 33.33% to A$0.012 on March 20, 2026, driven by unusually heavy volume of 4.28 million shares, nearly seven times the average. The stock broke above its 50-day and 200-day moving averages, indicating increased short-term trader interest in this clinical-stage biotech focused on osteoarthritis and wound healing. Despite negative earnings per share and liquidity constraints, the price action reflects momentum trading in a volatile sector. Traders should watch intraday support at A$0.010 and resistance near the year high of A$0.020. With a Meyka AI rating of 64.90 (Grade B), the stock is rated HOLD amid high volatility and thin order books typical of small-cap biotechs on the Australian Securities Exchange (ASX).
Go toTop